NSC |
Compound |
Enrichment |
Correlation |
NSC 90810 |
Null |
0.0291420747327558 |
0.14806282 |
NSC 13275 |
Null |
0.029142074732756 |
0.28404757 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.029142074732756 |
0.290917 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.029142074732756 |
-0.15299356 |
NSC 164970 |
Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- |
0.029142074732756 |
0.21447304 |
NSC 178248 |
Chlorozotocin |
0.029142074732756 |
0.20934028 |
NSC 248040 |
Null |
0.029142074732756 |
0.11477593 |
NSC 252628 |
1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)seleno]- |
0.029142074732756 |
0.33252843 |
NSC 602617 |
Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- |
0.0321614375606958 |
0.074634956 |
NSC 642968 |
Benzo[g]quinoline-5,10-dione, 5,10-dihydro- 4-[2-(1-piperidinyl)ethenyl]- |
0.0321614375606958 |
0.11514833 |